CURE Global X S&P Biotech ETF

$73.86−5.6%
Compare CURE with another fund →

Global X S&P Biotech ETF is a sector & thematic ETF from Global X — 157 holdings, with $39.6m under management. 88% of its money is in health care. Its two largest holdings, MODERNA INC and TWIST BIOSCIENCE, make up 4% of the fund. It charges 0.45% a year.

the last 3 months

$10,000 in CURE fell to $9,441.

No payout is counted in this period.

−5.59% by price

▲ ①What added the most

One company added the most: Moderna

Moderna added +$114 on every $10,000. Its share price rose 34% over the period, in its own currency. On average $253 of every $10,000 in CURE was in Moderna.

What moved it

The other 137together−$713
All companies together−$888

▼ ②6 Nov · What took the most

One sector took the most: Health Care

Health Care took $888 on every $10,000. On average $8,835 of every $10,000 in CURE was in it. The biggest part: Arrowhead, −$69.

Where they are

The companies by country

On $10,000 at the start

$10,000 at the start
Touch the line for a date and price
Start
$10,000
End
$9,441
High
$10,284
Low
$9,100

High and low were 12% apart.

How it adds up, on $10,000

Pricewhat the price did−$559

What you own

Of every $10,000 in CURE

  • Moderna$253
  • Twist$181
  • Natera$161
  • The other 140$9,405

The news · estimated

What the news did

Results above what was expected added +$201; results below what was expected took $147 on $10,000.

Results above what was expected+$20119 companiesBiggest: Praxis, 10 Nov, +$24
Results below what was expected−$14711 companiesBiggest: Alnylam Pharma, 30 Oct, −$33

Other news

Days with no flagged newsEvery other day: moves too small to flag−$801

How is the site working for you?